Intuitive Surgical, Inc. $ISRG Shares Purchased by Mackenzie Financial Corp

Mackenzie Financial Corp boosted its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 6.1% in the third quarter, Holdings Channel.com reports. The fund owned 263,013 shares of the medical equipment provider’s stock after buying an additional 15,065 shares during the quarter. Mackenzie Financial Corp’s holdings in Intuitive Surgical were worth $117,627,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other large investors also recently bought and sold shares of the stock. Tobam increased its position in shares of Intuitive Surgical by 666.7% during the second quarter. Tobam now owns 46 shares of the medical equipment provider’s stock worth $25,000 after purchasing an additional 40 shares in the last quarter. Kilter Group LLC purchased a new stake in shares of Intuitive Surgical in the 2nd quarter valued at about $27,000. Greykasell Wealth Strategies Inc. acquired a new stake in shares of Intuitive Surgical in the 3rd quarter valued at about $27,000. Caitlin John LLC acquired a new stake in shares of Intuitive Surgical in the 3rd quarter valued at about $30,000. Finally, Guerra Advisors Inc purchased a new position in Intuitive Surgical during the 3rd quarter worth approximately $37,000. Institutional investors and hedge funds own 83.64% of the company’s stock.

Wall Street Analysts Forecast Growth

Several research analysts have commented on ISRG shares. The Goldman Sachs Group reiterated a “buy” rating and issued a $714.00 price objective on shares of Intuitive Surgical in a research note on Friday, January 9th. Zacks Research upgraded shares of Intuitive Surgical from a “hold” rating to a “strong-buy” rating in a research report on Thursday, February 19th. Sanford C. Bernstein lifted their target price on shares of Intuitive Surgical from $740.00 to $750.00 and gave the company an “outperform” rating in a report on Friday, January 23rd. Barclays set a $712.00 price target on shares of Intuitive Surgical and gave the company an “overweight” rating in a research report on Monday, January 26th. Finally, Weiss Ratings reiterated a “hold (c+)” rating on shares of Intuitive Surgical in a research note on Monday, December 29th. Two analysts have rated the stock with a Strong Buy rating, sixteen have assigned a Buy rating, six have given a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average price target of $615.86.

Insider Buying and Selling

In related news, SVP Mark Brosius sold 645 shares of Intuitive Surgical stock in a transaction on Monday, March 9th. The shares were sold at an average price of $485.01, for a total value of $312,831.45. Following the transaction, the senior vice president directly owned 1,613 shares in the company, valued at $782,321.13. This trade represents a 28.57% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Also, SVP Patricia L. Wadors sold 220 shares of the business’s stock in a transaction on Friday, February 27th. The shares were sold at an average price of $499.71, for a total transaction of $109,936.20. The disclosure for this sale is available in the SEC filing. Insiders sold 37,907 shares of company stock valued at $19,997,187 in the last ninety days. Company insiders own 0.70% of the company’s stock.

Trending Headlines about Intuitive Surgical

Here are the key news stories impacting Intuitive Surgical this week:

• Positive Sentiment: Citi upgraded ISRG to Buy and set a $590 price target, calling out resilient med‑tech fundamentals — a clear near‑term catalyst that likely pushed buying interest. Read More.
• Positive Sentiment: Analyst coverage and commentary emphasize product momentum (da Vinci 5, Ion and SP platforms) and procedure growth, supporting revenue and recurring‑revenue visibility into 2026. Read More.
• Positive Sentiment: Intuitive closed the acquisition of regional da Vinci and Ion distribution businesses, consolidating distribution and potentially improving margin/recurring revenue capture. Read More.
• Neutral Sentiment: Seeking Alpha reiterated the company’s strong moat and solid Q4 results but flagged valuation (P/E ~63 vs. historical ~53) and recommended a Hold — this tempers upside for value‑oriented investors. Read More.
• Neutral Sentiment: MarketWatch noted ISRG outperformed peers on a strong trading day, reflecting today’s buying interest but not adding new fundamental news. Read More.
• Neutral Sentiment: MarketBeat’s roundup reiterates broad analyst support and a consensus target near $616, underpinning a constructive longer‑term view but noting mixed ratings (Buy/Hold). Read More.
• Negative Sentiment: Insider selling: multiple recent sales by senior executives (SVP Mark Brosius and EVP Myriam Curet) have been disclosed; while common for compensation/liquidity reasons, clustered insider sales can weigh on sentiment. Read More.

Intuitive Surgical Stock Up 1.4%

ISRG opened at $492.87 on Thursday. Intuitive Surgical, Inc. has a 52 week low of $425.00 and a 52 week high of $603.88. The business has a 50 day moving average price of $516.79 and a two-hundred day moving average price of $512.60. The company has a market cap of $175.03 billion, a PE ratio of 62.47, a P/E/G ratio of 3.75 and a beta of 1.66.

Intuitive Surgical (NASDAQ:ISRG) last announced its earnings results on Thursday, January 22nd. The medical equipment provider reported $2.53 earnings per share for the quarter, beating the consensus estimate of $2.27 by $0.26. The company had revenue of $2.87 billion for the quarter, compared to the consensus estimate of $2.72 billion. Intuitive Surgical had a return on equity of 15.06% and a net margin of 28.38%.The company’s revenue was up 18.8% on a year-over-year basis. During the same period last year, the business posted $2.21 EPS. As a group, sell-side analysts expect that Intuitive Surgical, Inc. will post 6.43 EPS for the current fiscal year.

Intuitive Surgical Profile

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.